Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 5, 2009, Pages 886-895

  Kersting, Stephan ^a   Konopke, Ralf ^a   Dittert, Dag ^a   Distler, Marius ^a   Rückert, Felix ^a   Gastmeier, Jörg ^a   Baretton, Gustavo B ^a   Saeger, Hans D ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Complications; Esophageal carcinoma; Neoadjuvant treatment; Survival

Indexed keywords

CISPLATIN; CONTRAST MEDIUM; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ADVANCED CANCER; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHYLOTHORAX; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE REDUCTION; ESOPHAGUS CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REGRESSION; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PATIENT SELECTION; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; TIME FACTORS; TREATMENT OUTCOME;

EID: 65949124901     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05732.x     Document Type: Article

References (37)

1. Bhansali MS, Vaidya JS, Bhatt RG, Patil PK, Badwe RA, Desai PB. Chemotherapy for carcinoma of the esophagus: a comparison of evidence from meta-analyses of randomized trials and of historical control studies. Ann. Oncol. 1996 7 : 355 9. (Pubitemid 26246786)
2. Donington JS, Miller DL, Allen MS, Deschamps C, Nichols FC 3rd., Pairolero PC. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur. J. Cardiothorac. Surg. 2003 24 : 631 6. Discussion F, Di Bona D, Schepis F et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004 53 : 925 30. (Pubitemid 37162533)
3. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J. Clin. Oncol. 2005 23 : 2310 17. (Pubitemid 46218723)
4. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J. Clin. Oncol. 2001 19 : 305 13. (Pubitemid 32112841)
5. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am. J. Surg. 2003 185 : 538 43.
6. Reynolds JV, Muldoon C, Hollywood D et al. Long-term outcomes following neoadjuvant chemoradiotherapy for esophageal cancer. Ann. Surg. 2007 245 : 707 16. (Pubitemid 46684100)
7. Mandard AM, Dalibard F, Mandard JC et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994 73 : 2680 6. (Pubitemid 24166250)
8. Hermann RM, Horstmann O, Haller F et al. Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use? Dis. Esophagus 2006 19 : 329 34.
9. American Joint Committee for Cancer Staging. Manual for Staging of Cancer, 3rd edn. Philadelphia, PA : Lippincott, 1988.
10. Sobin L, Wittekind C. WHO Staging Criteria (ed 4). New York : John Wiley-Liss, 1987.
11. Hermanek RP, Henson DE, Hutter RV, Sobin LH. International Union against Cancer: TNM Supplement. New York : Springer, 1993.
12. Cooper JS, Guo MD, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999 281 : 1623 7. (Pubitemid 29211772)
13. Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol. 2002 41 : 118 23.
14. Holscher AH, Metzger R, Schneider PM Preoperative radiochemotherapy of esophageal carcinoma. Light at the end of the tunnel? Zentralbl. Chir. 2000 125 : 319 25. (Pubitemid 30245761)
15. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1000 consecutive resections at a single center in the Western world. Ann. Surg. 2001 234 : 360 7. Discussion WA Jr., Rice TW, Adelstein DJ et al. Stage II esophageal carcinoma: the significance of T and N. J. Thorac. Cardiovasc. Surg. 1996 111 : 935 40. (Pubitemid 32847073)
16. Rice TW, Blackstone EH, Adelstein DJ et al. N1 esophageal carcinoma: the importance of staging and downstaging. J. Thorac. Cardiovasc. Surg. 2001 121 : 454 64. (Pubitemid 32230213)
17. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007 8 : 226 34. (Pubitemid 46291702)
18. Alexander EP, Lipman T, Harmon J, Wadleigh R. Aggressive multimodality therapy for stage III esophageal cancer: a phase I/II study. Ann. Thorac. Surg. 2000 69 : 363 8. (Pubitemid 30125560)
19. Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG. Neoadjuvant chemoradiotherapy for esophageal carcinoma. Dis. Esophagus 2005 18 : 104 8. (Pubitemid 40975422)
20. Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br. J. Surg. 2001 88 : 338 56. (Pubitemid 32238694)
21. Bedenne L, Michel P, Bouche O et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J. Clin. Oncol. 2007 25 : 1160 8. (Pubitemid 46640561)
22. Enzinger PC, Mayer RJ. Esophageal cancer. N. Engl. J. Med. 2003 349 : 2241 52. (Pubitemid 37485141)
23. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981 47 : 207 14. (Pubitemid 11167383)
24. Schneider PM, Baldus SE, Metzger R et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann. Surg. 2005 242 : 684 92. (Pubitemid 41567124)
25. Swisher SG, Hofstetter W, Wu TT et al. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann. Surg. 2005 241 : 810 17. Discussion BL, Stein HJ, Zimmermann F et al. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur. J. Surg. Oncol. 2004 30 : 963 71. (Pubitemid 40604927)
26. Berger AC, Farma J, Scott WJ et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J. Clin. Oncol. 2005 23 : 4330 7.
27. Aiko S, Yoshizumi Y, Ishizuka T et al. Reduction rate of lymph node metastasis as a significant prognostic factor in esophageal cancer patients treated with neoadjuvant chemoradiation therapy. Dis. Esophagus 2007 20 : 94 101.
28. Law S, Kwong DL, Wong KH, Kwok KF, Wong J. The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J. Gastrointest. Surg. 2006 10 : 1301 11.
29. Bosset JF, Gignoux M, Triboulet JP et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N. Engl. J. Med. 1997 337 : 161 7.
30. Putnam JB Jr., Suell DM, McMurtrey MJ et al. Comparison of three techniques of esophagectomy within a residency training program. Ann. Thorac. Surg. 1994 57 : 319 25. (Pubitemid 24101126)
31. Berger AC, Scott WJ, Freedman G et al. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer. Semin. Oncol. 2005 32 : S16 20. (Pubitemid 43080908)
32. Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br. J. Surg. 2006 93 : 1077 83. (Pubitemid 44343504)
33. Rasanen JV, Sihvo EI, Knuuti MJ et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann. Surg. Oncol. 2003 10 : 954 60. (Pubitemid 40486863)
34. Richards DG, Brown TH, Manson JM. Endoscopic ultrasound in the staging of tumours of the oesophagus and gastro-oesophageal junction. Ann. R. Coll. Surg. Engl. 2000 82 : 311 17.
35. Downey RJ, Akhurst T, Ilson D et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J. Clin. Oncol. 2003 21 : 428 32. (Pubitemid 46606470)
36. Lordick F, Ott K, Krause BJ et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol. 2007 8 : 797 805. (Pubitemid 47308659)
37. Ott K, Weber WA, Lordick F et al. Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction. J. Clin. Oncol. 2006 24 : 4692 8. (Pubitemid 46646244)